{
    "organizations": [],
    "uuid": "cd783c4c9ccecb76a91957b643bf4ca440be00b8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biolinerx-announces-partial-monoth/brief-biolinerx-announces-partial-monotherapy-results-from-phase-2a-combat-study-in-pancreatic-cancer-idUSFWN1PC0YH",
    "ord_in_thread": 0,
    "title": "BRIEF-Biolinerx Announces Partial Monotherapy Results From Phase 2A Combat Study In Pancreatic Cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 17 (Reuters) - Bioline Rx Ltd:\n* BIOLINERX ANNOUNCES PARTIAL MONOTHERAPY RESULTS FROM PHASE 2A COMBAT STUDY IN PANCREATIC CANCER\n* BIOLINE RX LTD - DATA TO BE PRESENTED AT UPCOMING ASCO-GI CONFERENCE; TOPLINE CLINICAL RESULTS EXPECTED BY H2 2018 AS PLANNED\n* BIOLINE RX LTD - BL-8040 MONOTHERAPY RESULTED IN INCREASED INFILTRATION OF T CELLS INTO TUMOR\n* BIOLINE RX LTD - PARTIAL RESULTS FROM BL-8040 MONOTHERAPY PORTION OF COMBAT TRIAL SHOW THAT BL-8040 WAS SAFE AND WELL-TOLERATED Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-17T21:00:00.000+02:00",
    "crawled": "2018-01-18T16:16:38.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "bioline",
        "rx",
        "ltd",
        "biolinerx",
        "announces",
        "partial",
        "monotherapy",
        "result",
        "phase",
        "2a",
        "combat",
        "study",
        "pancreatic",
        "cancer",
        "bioline",
        "rx",
        "ltd",
        "data",
        "presented",
        "upcoming",
        "conference",
        "topline",
        "clinical",
        "result",
        "expected",
        "h2",
        "planned",
        "bioline",
        "rx",
        "ltd",
        "monotherapy",
        "resulted",
        "increased",
        "infiltration",
        "cell",
        "tumor",
        "bioline",
        "rx",
        "ltd",
        "partial",
        "result",
        "monotherapy",
        "portion",
        "combat",
        "trial",
        "show",
        "safe",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}